资讯库
更紧凑的生命科学资讯库。
先搜索,再按来源或主题继续收窄。
罗氏早期giredestrant成果获赞 | ApexOnco - 临床试验新闻与分析 - 肿瘤学研发管线
Roche touts early giredestrant success | ApexOnco - Clinical Trials news and analysis Oncology Pipeline
罗氏制药管线进展与股价飙升17%后,是否该重新评估其投资时机? - simplywall.st
Is Now the Moment to Reassess Roche After Its Drug Pipeline Developments and 17% Stock Jump? simplywall.st
罗氏盈利展望:微调2025年销售预期,但多元化研发管线令人鼓舞——晨星加拿大
Roche Earnings: We’re Slightly Lowering Our 2025 Sales Forecast but Encouraged by Diverse Pipeline Morningstar Canada
罗氏推进新型骨髓瘤靶点研究 | ApexOnco - 临床试验新闻与分析 - 肿瘤学研发管线
Roche pushes a novel myeloma target | ApexOnco - Clinical Trials news and analysis Oncology Pipeline
罗氏凭借divarasib提前布局 | ApexOnco - 临床试验新闻与分析 - 肿瘤学研发管线
Roche looks earlier with divarasib | ApexOnco - Clinical Trials news and analysis Oncology Pipeline
罗氏在5,000名患者试验后放弃其TIGIT项目 | ApexOnco - 临床试验新闻与分析 - 肿瘤学研发管线
5,000 patients later Roche scraps its TIGIT | ApexOnco - Clinical Trials news and analysis Oncology Pipeline